Q2 2025 saw sharply lower revenue and ARR, but operational cost cuts improved EBITDA and cash flow. A fully subscribed rights issue bolstered liquidity, and a CEO transition was announced. Management expects stabilization and renewed growth in H2 2025.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.